Approval · Notice of Compliance 1853 · 1999
OXILAN: Notice of Compliance 1853
Issued October 5, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1853
- Date
- October 5, 1999
- Company
- Cook Imaging CorporationBloomington, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Nonionic contrast agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OXILAN | 02240929 | — |
| OXILAN | 02240930 | — |